Evaluation of the safety and tolerability of Neoral and Sandimmune: A meta-analysis

被引:5
|
作者
Shah, MB
Martin, JE
Schroeder, TJ
First, MR
机构
[1] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, Dept Pharm, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Med Ctr, Dept Internal Med, Cincinnati, OH 45267 USA
关键词
D O I
10.1016/S0041-1345(98)00397-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1697 / 1700
页数:4
相关论文
共 50 条
  • [1] The evaluation of the safety and tolerability of two formulations of cyclosporine: Neoral and sandimmune - A meta-analysis
    Shah, MB
    Martin, JE
    Schroeder, TJ
    First, MR
    TRANSPLANTATION, 1999, 67 (11) : 1411 - 1417
  • [2] A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral
    Shah, MB
    Martin, JE
    Schroeder, TJ
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 4048 - 4053
  • [3] Validity of open labeled versus blinded trials: A meta-analysis comparing neoral and sandimmune
    Shah, MB
    Martin, JE
    Schroeder, TJ
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 217 - 219
  • [4] Safety and tolerability of Sandimmune Neoral vs Sandimmune in de novo renal transplant patients after 24 months' treatment
    Buchholz, B
    Korn, A
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2187 - 2188
  • [5] Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients
    Grant, D
    Rochon, J
    Levy, G
    Cattral, M
    Cheung, S
    Grieg, P
    Altraif, I
    Rezieg, M
    Wong, PY
    Adams, P
    Asfar, S
    Freeman, D
    Ghent, C
    Wall, W
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2232 - 2233
  • [6] Meta-analysis of safety and tolerability with aripiprazole
    Carson, WH
    Stock, E
    Saha, AR
    Ali, M
    McQuade, RD
    Kujawa, MJ
    Ingenito, G
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 186 - 187
  • [7] Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients
    Barone, G
    Bunke, CM
    Choc, MG
    Hricik, DE
    Jin, JHJ
    Klein, JB
    Marsh, CL
    Min, DI
    Pescovitz, MD
    Pollak, R
    Pruett, TL
    Stinson, JB
    Thompson, JS
    Vasquez, E
    Waid, T
    Wombolt, DG
    Wong, RL
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2183 - 2186
  • [8] Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
    Gaston, R
    Alloway, RR
    Gaber, AO
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 326 - 327
  • [9] Safety and tolerability meta-analysis of aripiprazole in schizophrenia
    Carson, WH
    Stock, E
    Saha, AR
    Ali, MW
    McQuade, RD
    Kujawa, MJ
    Ingenito, G
    EUROPEAN PSYCHIATRY, 2002, 17 : 106S - 106S
  • [10] Safety and tolerability meta-analysis of aripiprazole in schizophrenia
    Stock, E
    Carson, WH
    Kaplita, SB
    Archibald, DG
    Marcus, R
    McQuade, RD
    Iwamoto, T
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 367 - 367